New York and Tokyo (February 21, 2021) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) announced a report sharing key policy-focused takeaways from their roundtable on antimicrobial resistance (AMR) in super-aging Japan. On October 7, 2020, the roundtable convened experts from across the business, government, academic, aging, and non-profit sectors in a policy discussion that recognized the multifaceted risks of AMR in aging societies around the world, including super-aging Japan.

A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines.

New York, NEW YORK (November 19, 2019) – The Global Coalition on Aging (GCOA) and Pfizer Global Medical Grants today officially launched a partnership to improve uptake of vaccines among Japanese older adults. Through $1 million USD in grant awards, the Vaccines for All: Longevity Unleashed for Everyone (VALUE) initiative will support, advance, and validate quality improvement strategies that measurably increase the number of older adults in Japan who are immunized against at least one targeted vaccine-preventable disease.

Helsinki, FINLAND (July 15, 2019) – Global, national, and local business and government leaders came together in Helsinki last week for the first time ever to drive action toward co-created innovation in products, services, and public policies that help enable and meet the needs of our growing global aging society.

Three GCOA-Led Symposia to Address Innovations in Skin Health, Elder Caregiving, Alzheimer’s Disease, Financial Services and Technology to Enable Healthy Aging NEW YORK (July 21, 2017) – The Global Coalition on Aging (GCOA), the leading business voice on aging, will be featured in three symposia at the 21st World Congress of the International Association of…